Assignee
REVIVA PHARMACEUTICALS INC
US·17 granted patents·6 pending applications·29 citations·filing 2007–2025
Top patents by PatentIndex Score
23 records- 0190US7989500B2Synthesis, methods of using, and compositions of cycloalkylmethylaminesREVIVA PHARMACEUTICALS INC·Filed 2007·Granted Aug 2, 2011·11 cites·15 claims
- 0285US9296681B2CycloalkylmethylaminesREVIVA PHARMACEUTICALS INC·Filed 2013·Granted Mar 29, 2016·2 cites·17 claims
- 0382US9255076B2Arylpiperazine derivatives and methods of utilizing sameREVIVA PHARMACEUTICALS INC·Filed 2015·Granted Feb 9, 2016·2 cites·19 claims
- 0479US9238625B2Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivativesREVIVA PHARMACEUTICALS INC·Filed 2012·Granted Jan 19, 2016·3 cites·11 claims
- 0578US8669285B2Synthesis, methods of using, and compositions of cycloalkylmethylaminesREVIVA PHARMACEUTICALS INC·Filed 2013·Granted Mar 11, 2014·2 cites·20 claims
- 0677US9907803B2Methods for treating attention deficit hyperactivity disorderREVIVA PHARMACEUTICALS INC·Filed 2016·Granted Mar 6, 2018·1 cites·15 claims
- 0777US8372883B2Methods of using cycloalkylmethylaminesREVIVA PHARMACEUTICALS INC·Filed 2011·Granted Feb 12, 2013·2 cites·21 claims
- 0876US9604944B2Arylpiperazine derivatives and methods of utilizing sameREVIVA PHARMACEUTICALS INC·Filed 2016·Granted Mar 28, 2017·1 cites·13 claims
- 0975US8980883B2Arylpiperazine derivatives and methods of utilizing sameREVIVA PHARMACEUTICALS INC·Filed 2014·Granted Mar 17, 2015·1 cites·20 claims
- 1074US8859552B2Methods of utilizing arylpiperazine derivativesREVIVA PHARMACEUTICALS INC·Filed 2013·Granted Oct 14, 2014·1 cites·20 claims
- 1173US12053477B2Methods for treating pulmonary fibrosisREVIVA PHARMACEUTICALS INC·Filed 2022·Granted Aug 6, 2024·0 cites·9 claims
- 1273US9695116B2Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivativesREVIVA PHARMACEUTICALS INC·Filed 2015·Granted Jul 4, 2017·1 cites·11 claims
- 1369US10441590B2Methods for treating pulmonary hypertensionREVIVA PHARMACEUTICALS INC·Filed 2017·Granted Oct 15, 2019·2 cites·10 claims
- 1466US9975862B2Arylpiperazine derivatives and methods of utilizing sameREVIVA PHARMACEUTICALS INC·Filed 2017·Granted May 22, 2018·0 cites·7 claims
- 1565US9096515B2Methods of using cycloalkylmethylamine derivativesREVIVA PHARMACEUTICALS INC·Filed 2013·Granted Aug 4, 2015·0 cites·20 claims
- 1664US9302981B2Synthesis, methods of using, and compositions of cycloalkylmethylaminesREVIVA PHARMACEUTICALS INC·Filed 2014·Granted Apr 5, 2016·0 cites·21 claims
- 1763US2026021105A1Method for treating psoriasisREVIVA PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1863US2026021104A1Brilaroxazine liposome compositionREVIVA PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1961US2021128570A1Methods for treating pulmonary fibrosisREVIVA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2058US10035761B2Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivativesREVIVA PHARMACEUTICALS INC·Filed 2017·Granted Jul 31, 2018·0 cites·13 claims
- 2140US2018071299A1Methods for treating psychosis associated with parkinson's diseaseREVIVA PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2239US2019142838A1Methods for treating parkinson's diseaseREVIVA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2335US2018071298A1Methods for treating alzheimer's diseaseREVIVA PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when REVIVA PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →